Liver Diseases  >>  Intron A (interferon α-2b)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intron A (interferon α-2b) / Merck (MSD), Biogen
NCT00140725: Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Completed
3
160
RoW
Lamivudine plus Polyethylene glyco-interferon alfa-2b, Lamivudine
GlaxoSmithKline
Chronic Hepatitis B
 
 

Download Options